Investigations into the physiological role of muscarinic M 2 and M 4 muscarinic and M 4 receptor subtypes using receptor knockout mice

Life Sciences

Volumn 68, Issue 22-23, 2001, Pages 2473-2479

  Bymaster, Frank P ^a   Carter, Petra A ^a   Zhang, Lu ^a   Falcone, Julie F ^a   Stengel, Peter W ^a   Cohen, Marlene L ^a   Shannon, Harlan E ^a   Gomeza, Jesus ^b   Wess, Jürgen ^b   Felder, Christian C ^a  

^a ELI LILLY AND COMPANY   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Atria; Gene knockout; Hypothermia; Muscarinic M 2 receptors; Muscarinic M 4 receptors; Muscarinic receptor; Salivation; Tremor

Indexed keywords

CARBACHOL; MUSCARINIC RECEPTOR; OXOTREMORINE; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER CONTRACTION; BRADYCARDIA; DRUG EFFECT; DRUG POTENCY; DRUG RECEPTOR BINDING; HEART ATRIUM; HYPOTHERMIA; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; SALIVATION; SMOOTH MUSCLE CONTRACTION; STOMACH FUNDUS; TRACHEA; TREMOR;

EID: 0035957621     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(01)01041-4     Document Type: Conference Paper

References (16)

1. A.I. Levey, Life Sci. 52: 441-448 (1993).
2. S.E. Hamilton, M.D. Loose, M. Qi, A.I. Levey, B Hille, G.S. McKnight, R. Idzerda, N.M. Nathanson, Proc. Natl. Acad. Sci. USA 94: 13311-13316 (1997).
3. J. Gomeza, H.E. Shannon, E. Kostenis, C. Felder, L. Zhang, J. Brodkin, A. Grinberg, H. Sheng, J. Wess, Proc. Natl. Acad. Sci. USA, 96: 1692-1697 (1999).
4. M. Matsui, D. Motomura, H. Karasawa, T. Fujikawa, J. Jiang, Y. Komiya, S-i. Takahashi, M.M. Taketo, Proc. Natl. Acad. Sci. USA 97: 9579-9584 (2000).
5. J. Gomeza, L. Zhang, J. Brodkin, F.P. Bymaster, C.C. Felder, H.E. Shannon, B. Xia, E. Kostenis, C-X Deng, J. Wess, J, Proc. Natl. Acad. Sci. USA, 96: 10483-10488 (1999).
6. M.P. Caulfield, Pharmacol. Ther. 58: 319-379 (1993).
7. F.P. Bymaster, I. Heath, J.C. Hendrix, H.E. Shannon He, J. Pharmacol. Exp. Ther. 267: 16-24 (1993).
8. F.P. Bymaster, H.E. Shannon, K. Rasmussen, N.W. Delapp, C.H. Mitch, J.S. Ward, D.O. Calligaro, T.S. Ludvigsen, M.J, Sheardown, P.H. Olesen, M.D.B. Swedberg, P. Sauerberg, A. Fink-Jensen, Eur. J. Pharmacol. 358: 109-119 (1998).
9. F.P. Bymaster, H.E. Shannon, K. Rasmussen, N.W. Delapp, J.S. Ward, D.O. Calligaro, C.H. Mitch, C. Whitesitt, T.S. Ludvigsen, M. Sheardown, M. Swedberg M, T. Rasmussen, P.H. Olesen, L. Jeppesen, P. Sauerberg P, A. Fink-Jensen, Life Sci. 64: 527-534 (1999).
10. K.W. Perry, L. Nisenbaum, C.A. George, H.E. Shannon, C.C. Felder, F.P. Bymaster, Biol. Psychiatry, in press (2000).
11. E.G. Peralta, A. Ashkenazi, J.W. Winslow, J. Ramachandran, D.J. Capon, Nature, Lond. 334: 434-437 (1988).
12. P.W. Stengel, J. Gomeza, J. Wess, M.L. Cohen, J. Pharmacol. Exp. Ther. 292: 877-885 (2000).
13. F.P. Bymaster, D.T. Wong, C.H. Mitch, J.S. Ward, D.O. Calligaro, D.D. Schoepp DD, H.E. Shannon, M.J. Sheardown, P.H. Olesen, P.D. Suzdak, M.D.B. Swedberg, P. Sauerberg, J. Pharmacol. Exp. Ther. 269: 282-289 (1994).
14. G. Di Chiara, M. Morelli, S. Consolo, Trends Neurosci. 17: 228-233 (1994).
15. M. Gillard, M. Waelbroeck, J. Christophe, Mol. Pharmacol. 32: 100-108 (1987).
16. S.B. Freedman, E.A. Harley, L.L. Iversen, Br. J. Pharmacol. 93: 437-445 (1998).